Hannah H. Chang

Physician scientist, life sciences VC, former BCG consultant

[Korro Bio @KorroBio]

We are excited to enter into a definitive merger agreement with @frequencytx. The newly established company will focus on advancing Korro’s proprietary RNA editing platform and portfolio of RNA editing programs, including our lead AATD product candidate: https://t.co/zpW0uPyR4p

[Endpoints News @endpts]

A radical new way of treating type 1 diabetes keeps producing promising early data, raising hopes that a cell therapy might one day become a cure for the disease.

https://t.co/7o1lwa2MlW

[Hannah H. Chang @HannahHChang]

Proud spouse - congratulations Kyle Farh!

https://t.co/PK8WVKfm3E

[Hannah H. Chang @HannahHChang]

Congratulations to my husband Kyle Farh on the publication of what we endearingly call “the monkey papers” in our house! These four articles show their innovative work developing PrimateAI-3D, an AI algorithm that predicts disease-causing variants with unprecedented accuracy.

[Hannah H. Chang @HannahHChang]

We couldn't be more excited to be a partner to Ray Therapeutics as they develop transformative optogenetics gene therapeutics for blinding retinal diseases.

Ray Therapeutics snags $100M for optogenetics gene therapy - https://t.co/HONpLRzdFv

[Hannah H. Chang @HannahHChang]

We couldn’t be more excited to welcome Julie to Nuvig! Thank you Pam for your leadership and fortitude. Looking forward to working with you both. https://t.co/cDE6xUruVc

[Hannah H. Chang @HannahHChang]

Congratulations to PACT Pharma on this bold and innovative work. https://t.co/3Znsbw0iqS

[Hannah H. Chang @HannahHChang]

Congrats Akouos! https://t.co/8NgOeghT84

[Hannah H. Chang @HannahHChang]

@nuvigtx @novoholdings @bmsnews @digitalisvc @MissionBioCap We couldn’t be more thrilled to be a partner to Nuvig and our esteemed investor colleagues in this exciting new endeavor.

[Nuvig Therapeutics @nuvigtx]

We are excited to announce our launch today! We are developing novel immune therapeutics for chronic inflammatory and #autoimmunediseases.

Thank you to our investors! @novoholdings, Platanus, @bmsnews, @digitalisvc, and @MissionBioCap

https://t.co/ltabObZJoP

#biotech #BayArea

[Hannah H. Chang @HannahHChang]

Always insightful - a must read! According to @SVB_Financial’s annual report, healthcare venture investment and fundraising both hit record highs in 2021 https://t.co/kPJMryR3gn #SVBHealthcare @jonnysvb

[Hannah H. Chang @HannahHChang]

https://t.co/wUur4yDVrB

[Hannah H. Chang @HannahHChang]

Such exciting news! Hats off to the Semma / Vertex teams. https://t.co/ujxHDS8Ehz

[Hannah H. Chang @HannahHChang]

Vertex Shares "Unprecedented" Results in Early-Stage Type 1 Diabetes Trial | BioSpace https://t.co/OahtHaxb0h #jobs

[Hannah H. Chang @HannahHChang]

Inipharm to Present Data Showing Potential of Small Molecule Inhibitors of HSD17B13 to Combat Liver Fibrosis at AASLD’s The Liver Meeting | Business Wire https://t.co/B3MFXHrp2s

[Hannah H. Chang @HannahHChang]

https://t.co/5oDvIMsP8Q

[Hannah H. Chang @HannahHChang]

@AlexHarding7 I agree and just keep this in mind: basically all adults are potty trained, which means you are going through a process that has ~100% success rate. Imagine if that were true for therapeutics R&D. Hang in there!

[Hannah H. Chang @HannahHChang]

Korro Bio Appoints Vineet Agarwal as Chief Financial Officer | Business Wire https://t.co/AmeepQQAnm

[Hannah H. Chang @HannahHChang]

Gemini Therapeutics Appoints Samuel Barone, M.D., as Chief Medical Officer | BioSpace https://t.co/BPK9f0tMMY #jobs

[Hannah H. Chang @HannahHChang]

Kati Kariko Helped Shield the World From the Coronavirus https://t.co/5GX6bmzl2k